Immix Biopharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLEICHROEDER LP | 02/14/2025 | 850,000 | $1.87 M | 0.00% | 2.89% |
CABLE CAR CAPITAL LLC | 02/14/2025 | 796,100 | $1.75 M | 0.00% | 2.71% |
VANGUARD GROUP INC | 02/11/2025 | 698,537 | $1.54 M | 0.00% | 2.37% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 150,082 | $330,234 | 0.00% | 0.51% |
STATE STREET CORP | 02/14/2025 | 42,960 | $94,512 | 0.00% | 0.15% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/10/2025 | 38,300 | $84,260 | -11.55% | 0.13% |
PRIVATE ADVISOR GROUP, LLC | 02/03/2025 | 31,225 | $68,695 | -9.03% | 0.11% |
FNY INVESTMENT ADVISERS, LLC | 01/13/2025 | 28,750 | $63,000 | 100.00% | 0.10% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 25,860 | $57,000 | -0.84% | 0.09% |
JANE STREET GROUP, LLC | 02/14/2025 | 17,523 | $38,551 | 100.00% | 0.06% |
02/06/2025 | 17,500 | $38,500 | 100.00% | 0.06% | |
UBS GROUP AG | 02/14/2025 | 14,208 | $31,258 | 131.17% | 0.05% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 14,076 | $30,967 | 0.52% | 0.05% |
COLONY GROUP, LLC | 02/14/2025 | 11,900 | $26,180 | 0.00% | 0.04% |
ROYAL BANK OF CANADA | 02/14/2025 | 2,000 | $4,000 | -97.62% | 0.01% |
TORTOISE INVESTMENT MANAGEMENT, LLC | 02/07/2025 | 1,300 | $2,860 | 0.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 330 | $726 | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 181 | $398 | -94.18% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 38 | $84 | 100.00% | 0.00% |
OLD NATIONAL BANCORP /IN/ | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
AIGH CAPITAL MANAGEMENT LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
INVST, LLC | 02/19/2025 | 0 | $0 | -100.00% | 0.00% |
TRITONPOINT WEALTH, LLC | 01/24/2025 | 0 | $0 | -100.00% | 0.00% |
Immix Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Immix Biopharma, Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 850,000
Cable Car Capital LLC: 796,100
VANGUARD GROUP INC: 698,537
GEODE CAPITAL MANAGEMENT, LLC: 150,082
STATE STREET CORP: 42,960
TOCQUEVILLE ASSET MANAGEMENT L.P.: 38,300
9.76% of Immix Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.30 M shares in the last 24 months. This purchase volume represents approximately $7.60 M in transactions.